|
2024
|
Invention
|
Therapeutic regimens and methods of treatment of nash using mutant fgf-21 peptide conjugates. The... |
|
|
Invention
|
Chemical synthesis of cytidine-5'-monophospho-n-glycyl-sialic acid.
Aspects of the present discl... |
|
|
Invention
|
Compositions and methods of treatment for severe hypertriglyceridemia.
Compositions, methods and... |
|
2023
|
Invention
|
Liquid formulations comprising mutant fgf-21 peptide pegylated conjugates. The present disclosure... |
|
|
Invention
|
Methods of treatment of nash using mutant fgf-21 peptide conjugates |
|
|
Invention
|
Methods of treatment of nash using mutant fgf-21 peptide conjugates. Therapeutic regimens and use... |
|
|
Invention
|
Compositions and methods of treatment for severe hypertriglyceridemia |
|
|
Invention
|
Compositions and methods of treatment for severe hypertriglyceridemia. Compositions, methods and ... |
|
2022
|
Invention
|
Chemical synthesis of cytidine-5'-monophospho-n-glycyl-sialic acid. Aspects of the present disclo... |
